<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045155"><TermName>cytarabine</TermName><TermPronunciation>(sy-TAYR-uh-been)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat certain types of leukemia and prevent the spread of leukemia to the meninges (three thin layers of tissue that cover and protect the brain and spinal cord). It is also being studied in the treatment of other types of cancer. Cytarabine blocks tumor growth by stopping DNA synthesis. It is a type of antimetabolite.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705092" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;cytarabine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705093" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;citarabina&quot;" language="es" id="_4"/><SpanishTermName>citarabina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar ciertos tipos de leucemia y prevenir la diseminación de la leucemia hacia las meninges (tres capas finas de tejido que cubren y protegen el cerebro y la médula espinal). Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. La citarabina bloquea el crecimiento del tumor porque detiene la síntesis del ADN. Es un tipo de antimetabolito.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-12-03</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000540242">Cytarabine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
